Taiwan Bio Therapeutics Co., Ltd (6892.TWO)

TWD 38.9

(-0.13%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 85.47 Million 44.74 Million 27.15 Million - -
Cost of Revenue 9.11 Million 13.07 Million 4.51 Million - -
Gross Profit 76.35 Million 31.66 Million 22.64 Million - -
Operating Expenses 290.95 Million 218.31 Million 109.68 Million 35.81 Million -
Selling, General and Administrative Expenses 46.3 Million 36.75 Million 17.12 Million 4.43 Million -
Research and Development Expenses 244.64 Million 181.55 Million 92.56 Million 31.38 Million -
Other Expenses -48 Thousand 2.87 Million -365 Thousand 882 Thousand -
Cost and Expenses 300.06 Million 231.39 Million 114.19 Million 35.81 Million -
Operating Income -212.2 Million -182.59 Million -87.34 Million -34.92 Million -
Interest Expense 5.3 Million 5.42 Million 2.85 Million 117 Thousand -
Income Tax Expense - 544 Thousand - - -
Earnings before Tax -217.51 Million -188.01 Million -90.2 Million -35.03 Million -
Net Income -217.51 Million -188.56 Million -90.2 Million -35.03 Million -
Earnings Per Share Basic -5.73 -3.81 -3.05 -3.65 -3.72
Earnings Per Share Diluted -5.73 -3.81 -3.05 -3.65 -3.72
Weighted Average Shares Outstanding 37.95 Million 49.53 Million 29.61 Million 9.61 Million 7.01 Million
Weighted Average Shares Outstanding (Diluted) 37.95 Million 49.53 Million 29.61 Million 9.61 Million 7.01 Million
Gross Margin 0.89 0.71 0.83 - -
EBIT Margin -1.71 -2.89 -2.15 - -
Profit Margin -2.54 -4.21 -3.32 - -
EBITDA -145.97 Million -129.46 Million -58.43 Million -32.26 Million -
Earnings Before Tax Margin -2.48 -4.08 -3.22 - -

Income Statement Charts